Microbot Medical Inc. (MBOT)
USD 1.39
(-7.95%)
USD 1.39
(-7.95%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.28 Million USD | -15.45% |
| 2022 | -1.98 Million USD | 84.55% |
| 2021 | -12.81 Million USD | 31.98% |
| 2020 | -18.83 Million USD | 32.41% |
| 2019 | -27.86 Million USD | -432.04% |
| 2018 | -5.23 Million USD | 51.44% |
| 2017 | -10.78 Million USD | -309.68% |
| 2016 | -2.63 Million USD | -48.17% |
| 2015 | -1.77 Million USD | 82.17% |
| 2014 | -9.96 Million USD | 43.61% |
| 2013 | -17.67 Million USD | -117.67% |
| 2012 | -8.12 Million USD | 36.41% |
| 2011 | -12.77 Million USD | 32.51% |
| 2010 | -18.92 Million USD | 49.68% |
| 2009 | -37.6 Million USD | -29.63% |
| 2008 | -29 Million USD | -238.45% |
| 2007 | -8.57 Million USD | 83.01% |
| 2006 | -50.44 Million USD | -47.36% |
| 2005 | -34.23 Million USD | 12.49% |
| 2004 | -39.11 Million USD | -255.76% |
| 2003 | -10.99 Million USD | -472.5% |
| 2002 | -1.92 Million USD | 82.69% |
| 2001 | -11.09 Million USD | -254.17% |
| 2000 | -3.13 Million USD | -108.96% |
| 1999 | -1.49 Million USD | 46.47% |
| 1998 | -2.8 Million USD | 73.83% |
| 1997 | -10.7 Million USD | -1.9% |
| 1996 | -10.5 Million USD | -250.0% |
| 1995 | -3 Million USD | -42.86% |
| 1994 | -2.1 Million USD | 51.16% |
| 1993 | -4.3 Million USD | -86.96% |
| 1992 | -2.3 Million USD | 83.09% |
| 1991 | -13.6 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1 Million USD | 56.17% |
| 2024 Q2 | -2.36 Million USD | -131.24% |
| 2023 Q4 | -2.28 Million USD | -109.72% |
| 2023 Q2 | -5.4 Million USD | -207.57% |
| 2023 Q1 | -1.75 Million USD | 11.26% |
| 2023 FY | -2.28 Million USD | -15.45% |
| 2023 Q3 | -1.09 Million USD | 79.83% |
| 2022 Q4 | -1.98 Million USD | 48.28% |
| 2022 Q1 | -9.77 Million USD | 23.75% |
| 2022 FY | -1.98 Million USD | 84.55% |
| 2022 Q3 | -3.82 Million USD | 43.04% |
| 2022 Q2 | -6.72 Million USD | 31.21% |
| 2021 Q2 | -14.91 Million USD | 13.24% |
| 2021 Q1 | -17.18 Million USD | 8.76% |
| 2021 FY | -12.81 Million USD | 31.98% |
| 2021 Q4 | -12.81 Million USD | -0.69% |
| 2021 Q3 | -12.72 Million USD | 14.66% |
| 2020 FY | -18.83 Million USD | 32.41% |
| 2020 Q2 | -27.37 Million USD | 4.66% |
| 2020 Q3 | -25.71 Million USD | 6.06% |
| 2020 Q1 | -28.71 Million USD | -3.04% |
| 2020 Q4 | -18.83 Million USD | 26.76% |
| 2019 Q2 | -4.38 Million USD | 8.51% |
| 2019 Q3 | -3.1 Million USD | 29.27% |
| 2019 Q1 | -4.79 Million USD | 8.46% |
| 2019 FY | -27.86 Million USD | -432.04% |
| 2019 Q4 | -27.86 Million USD | -798.1% |
| 2018 Q3 | -6.67 Million USD | 16.8% |
| 2018 FY | -5.23 Million USD | 51.44% |
| 2018 Q1 | -9.46 Million USD | 12.3% |
| 2018 Q2 | -8.02 Million USD | 15.22% |
| 2018 Q4 | -5.23 Million USD | 21.5% |
| 2017 Q4 | -10.78 Million USD | 8.03% |
| 2017 Q3 | -11.72 Million USD | 10.32% |
| 2017 Q2 | -13.07 Million USD | -174.92% |
| 2017 FY | -10.78 Million USD | -309.68% |
| 2017 Q1 | -4.75 Million USD | -80.67% |
| 2016 FY | -2.63 Million USD | -48.17% |
| 2016 Q1 | 629.88 Thousand USD | 135.45% |
| 2016 Q2 | -2.44 Million USD | -488.57% |
| 2016 Q4 | -2.63 Million USD | -3249.11% |
| 2016 Q3 | -78.61 Thousand USD | 96.79% |
| 2015 FY | -1.77 Million USD | 82.17% |
| 2015 Q1 | -749.25 Thousand USD | 92.48% |
| 2015 Q2 | -17.5 Million USD | -2235.76% |
| 2015 Q3 | -9.77 Million USD | 44.14% |
| 2015 Q4 | -1.77 Million USD | 81.82% |
| 2014 Q2 | -2.84 Million USD | 72.87% |
| 2014 Q4 | -9.96 Million USD | 38.64% |
| 2014 Q1 | -10.5 Million USD | 40.58% |
| 2014 FY | -9.96 Million USD | 43.61% |
| 2014 Q3 | -16.24 Million USD | -470.13% |
| 2013 Q3 | -7.25 Million USD | 43.86% |
| 2013 Q4 | -17.67 Million USD | -143.73% |
| 2013 FY | -17.67 Million USD | -117.67% |
| 2013 Q1 | -6.93 Million USD | 14.64% |
| 2013 Q2 | -12.91 Million USD | -86.37% |
| 2012 Q2 | -6.77 Million USD | 24.56% |
| 2012 Q3 | -15.31 Million USD | -126.05% |
| 2012 Q4 | -8.12 Million USD | 46.96% |
| 2012 FY | -8.12 Million USD | 36.41% |
| 2012 Q1 | -8.97 Million USD | 29.69% |
| 2011 Q3 | -6.68 Million USD | -14.01% |
| 2011 Q1 | -12.34 Million USD | 34.79% |
| 2011 Q4 | -12.77 Million USD | -90.9% |
| 2011 FY | -12.77 Million USD | 32.51% |
| 2011 Q2 | -5.86 Million USD | 52.45% |
| 2010 Q1 | -30.38 Million USD | 19.21% |
| 2010 FY | -18.92 Million USD | 49.68% |
| 2010 Q4 | -18.92 Million USD | 20.19% |
| 2010 Q3 | -23.71 Million USD | 20.61% |
| 2010 Q2 | -29.86 Million USD | 1.7% |
| 2009 Q1 | -32.91 Million USD | -13.48% |
| 2009 FY | -37.6 Million USD | -29.63% |
| 2009 Q4 | -37.6 Million USD | -38.48% |
| 2009 Q3 | -27.15 Million USD | 23.79% |
| 2009 Q2 | -35.63 Million USD | -8.24% |
| 2008 Q1 | -11.45 Million USD | -33.69% |
| 2008 FY | -29 Million USD | -238.45% |
| 2008 Q4 | -29 Million USD | -92.17% |
| 2008 Q3 | -15.09 Million USD | 13.63% |
| 2008 Q2 | -17.47 Million USD | -52.53% |
| 2007 Q1 | -49.63 Million USD | 1.6% |
| 2007 Q2 | -47.9 Million USD | 3.48% |
| 2007 FY | -8.57 Million USD | 83.01% |
| 2007 Q4 | -8.57 Million USD | 47.43% |
| 2007 Q3 | -16.3 Million USD | 65.97% |
| 2006 Q1 | -29.27 Million USD | 14.47% |
| 2006 Q3 | -54.02 Million USD | 7.45% |
| 2006 FY | -50.44 Million USD | -47.36% |
| 2006 Q2 | -58.37 Million USD | -99.37% |
| 2006 Q4 | -50.44 Million USD | 6.63% |
| 2005 Q1 | -35.53 Million USD | 9.16% |
| 2005 FY | -34.23 Million USD | 12.49% |
| 2005 Q2 | -34.59 Million USD | 2.63% |
| 2005 Q4 | -34.23 Million USD | -2.96% |
| 2005 Q3 | -33.24 Million USD | 3.9% |
| 2004 Q1 | -8.31 Million USD | 24.35% |
| 2004 FY | -39.11 Million USD | -255.76% |
| 2004 Q2 | -24.05 Million USD | -189.16% |
| 2004 Q3 | -21.23 Million USD | 11.73% |
| 2004 Q4 | -39.11 Million USD | -84.23% |
| 2003 Q4 | -10.99 Million USD | -443.12% |
| 2003 Q1 | 710.13 Thousand USD | 136.98% |
| 2003 Q3 | -2.02 Million USD | 53.26% |
| 2003 Q2 | -4.33 Million USD | -709.89% |
| 2003 FY | -10.99 Million USD | -472.5% |
| 2002 Q1 | -8.1 Million USD | 26.91% |
| 2002 FY | -1.92 Million USD | 82.69% |
| 2002 Q4 | -1.92 Million USD | 55.32% |
| 2002 Q3 | -4.29 Million USD | 19.57% |
| 2002 Q2 | -5.34 Million USD | 34.08% |
| 2001 Q3 | -9.16 Million USD | -37.47% |
| 2001 Q4 | -11.09 Million USD | -21.02% |
| 2001 FY | -11.09 Million USD | -254.17% |
| 2001 Q1 | -1.64 Million USD | 47.49% |
| 2001 Q2 | -6.66 Million USD | -305.4% |
| 2000 Q1 | -1.32 Million USD | 11.87% |
| 2000 FY | -3.13 Million USD | -108.96% |
| 2000 Q2 | -2.43 Million USD | -84.26% |
| 2000 Q3 | -4.22 Million USD | -73.68% |
| 2000 Q4 | -3.13 Million USD | 25.92% |
| 1999 Q4 | -1.49 Million USD | -399.6% |
| 1999 Q1 | -700 Thousand USD | 75.0% |
| 1999 FY | -1.49 Million USD | 46.47% |
| 1999 Q2 | -600 Thousand USD | 14.29% |
| 1999 Q3 | -300 Thousand USD | 50.0% |
| 1998 Q4 | -2.8 Million USD | 28.21% |
| 1998 Q2 | -6.8 Million USD | 28.42% |
| 1998 Q1 | -9.5 Million USD | 11.21% |
| 1998 FY | -2.8 Million USD | 73.83% |
| 1998 Q3 | -3.9 Million USD | 42.65% |
| 1997 FY | -10.7 Million USD | -1.9% |
| 1997 Q2 | -3.6 Million USD | 33.33% |
| 1997 Q3 | 2.2 Million USD | 161.11% |
| 1997 Q4 | -10.7 Million USD | -586.36% |
| 1997 Q1 | -5.4 Million USD | 48.57% |
| 1996 FY | -10.5 Million USD | -250.0% |
| 1996 Q4 | -10.5 Million USD | -356.52% |
| 1996 Q3 | -2.3 Million USD | -1050.0% |
| 1996 Q1 | 700 Thousand USD | 123.33% |
| 1996 Q2 | -200 Thousand USD | -128.57% |
| 1995 Q2 | -1.6 Million USD | -223.08% |
| 1995 FY | -3 Million USD | -42.86% |
| 1995 Q4 | -3 Million USD | -242.86% |
| 1995 Q3 | 2.1 Million USD | 231.25% |
| 1995 Q1 | 1.3 Million USD | 161.9% |
| 1994 Q1 | 2.8 Million USD | 165.12% |
| 1994 Q4 | -2.1 Million USD | -133.33% |
| 1994 Q3 | -900 Thousand USD | 95.65% |
| 1994 Q2 | -20.7 Million USD | -839.29% |
| 1994 FY | -2.1 Million USD | 51.16% |
| 1993 Q2 | 900 Thousand USD | -65.38% |
| 1993 Q4 | -4.3 Million USD | 0.0% |
| 1993 FY | -4.3 Million USD | -86.96% |
| 1993 Q1 | 2.6 Million USD | 213.04% |
| 1992 Q4 | -2.3 Million USD | 0.0% |
| 1992 FY | -2.3 Million USD | 83.09% |
| 1991 Q4 | -13.6 Million USD | 0.0% |
| 1991 FY | -13.6 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | 188.57% |
| AngioDynamics, Inc. | -70.14 Million USD | 96.741% |
| AtriCure, Inc. | -9.81 Million USD | 76.711% |
| Avinger, Inc. | 10.12 Million USD | 122.589% |
| Azenta, Inc. | -618.47 Million USD | 99.63% |
| BioLife Solutions, Inc. | 7.25 Million USD | 131.518% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 100.093% |
| Daxor Corporation | 755.65 Thousand USD | 402.517% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | -55.51% |
| Femasys Inc. | -15.01 Million USD | 84.775% |
| GlucoTrack, Inc. | -4.29 Million USD | 46.788% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 105.939% |
| Hologic, Inc. | 374.4 Million USD | 100.611% |
| ICU Medical, Inc. | 1.45 Billion USD | 100.158% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 99.914% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 67.515% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 55.818% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 46.682% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 46.682% |
| Masimo Corporation | 804 Million USD | 100.284% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 76.177% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 100.756% |
| Nephros, Inc. | -2.47 Million USD | 7.487% |
| NovoCure Limited | 355.42 Million USD | 100.643% |
| NEXGEL, Inc. | 98 Thousand USD | 2432.653% |
| NEXGEL, Inc. | 98 Thousand USD | 2432.653% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 103.871% |
| OraSure Technologies, Inc. | -276.9 Million USD | 99.174% |
| Pro-Dex, Inc. | 10.91 Million USD | 120.942% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 93.51% |
| Predictive Oncology Inc. | -5.87 Million USD | 61.068% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | 175.466% |
| QuidelOrtho Corporation | 2.49 Billion USD | 100.092% |
| Repligen Corporation | -39.51 Million USD | 94.215% |
| Sanara MedTech Inc. | 6.64 Million USD | 134.402% |
| STAAR Surgical Company | -147.2 Million USD | 98.447% |
| Sharps Technology, Inc. | -3.01 Million USD | 24.126% |
| Utah Medical Products, Inc. | -92.52 Million USD | 97.529% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 100.116% |
| Jin Medical International Ltd. | -2.81 Million USD | 18.836% |